D22.112
Melanocytic nevi of right lower eyelid, including canthus
Clinical Classification Guidelines
Medical Intelligence & Overview
Melanocytic nevi, commonly known as moles, are growths on the skin formed by clusters of melanocytes, the pigment-producing cells. Specifically, D22.112 pertains to melanocytic nevi located on the right lower eyelid, including the canthus (corner of the eye). While most nevi are benign and harmless, it's important to monitor them for any changes that could suggest malignancy. This guide provides an overview of this condition, including its causes, symptoms, diagnosis, and typical management approaches.
Causes & Symptoms
Clinical Causes: Genetic predisposition - family history of moles or pigmented lesions. Sun exposure - ultraviolet (UV) radiation can increase melanocyte activity and pigment production. Hormonal changes - puberty and hormonal fluctuations may influence the development and appearance of nevi. Multiple congenital moles - some individuals are born with multiple moles that may include areas around the eyelids. Skin type and pigmentation - variations in skin pigmentation and type can influence nevus development.
Key Symptoms: Appearance of a new pigmented lesion on the eyelid or changes in existing moles. A well-defined, round or oval, uniformly pigmented spot or bump. Color variations within the nevus, potentially including brown, black, or darker shades. Size changes over time, such as growth or shrinkage. Textural changes, like becoming rough, raised, or developing a surface irregularity. In rare cases, bleeding, ulceration, or itching may occur.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a visual examination of the lesion by a healthcare professional, focusing on attributes such as symmetry, border, color, diameter, and evolution—commonly summarized by the ABCDEs of pigmented lesions. In some cases, dermoscopy, a non-invasive skin imaging technique, may be used to examine the lesion more closely. If there is concern about malignancy or atypical features, a biopsy may be performed to obtain a tissue sample for histopathological analysis. This helps distinguish benign nevi from melanomas or other pigmented skin cancers.
Treatment Protocols: Treatment options depend on the characteristics of the nevus and any associated risk factors. Common management approaches include: - Observation: Regular monitoring for changes in size, shape, or color, especially if the lesion is benign and asymptomatic. - Surgical removal: Performed for diagnostic purposes, cosmetic reasons, or if malignancy is suspected. This involves excising the nevus under local anesthesia. - Laser or cryotherapy: Occasionally used for superficial pigmented lesions, though less commonly than surgical excision. Follow-up care is important to ensure proper healing and to monitor for any recurrence or new lesions. Decisions about treatment are made in consultation with a healthcare professional specializing in dermatology or oculoplastic surgery.
Clinical Advice & FAQs
Billing Guidance
Is D22.112 a billable ICD-10 code?
Yes, D22.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D22.112?
Clinical documentation must specify the nature of Melanocytic nevi of right lower eyelid, including canthus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference